Table 1.
General characteristics of the studied groups
| CWI group (n = 26) | SAPB group (n = 20) | p Value | |
|---|---|---|---|
| Sex ratio (M/F) | 18/8 | 10/10 | 0.23 |
| Age | 67 [64–72] | 67 [60–74] | 0.78 |
| BMI (kg/m2) | 27 [25–29] | 29 [23–31] | 0.50 |
| Euroscore 2 | 1.2 [0.8–2.0] | 0.9 [0.7–1.6] | 0.20 |
| Respiratory disease | 4 (15) | 4 (20) | 0.70 |
| Characteristics of the surgery | |||
| AVR | 21 (81) | 14 (70) | 0.49 |
| MVR | 4 (15.4) | 0 | 0.12 |
| Mitral valve plasty | 1 (3.9) | 5 (25) | 0.07 |
| CABG | 0 | 1 (5) | 0.46 |
| Duration of surgery (min) | 192 [170–227] | 194 [167–216] | 0.62 |
| Intraoperative data | |||
| Gabapentin | 25 (96) | 19 (94) | 0.76 |
| Ketamine | 8 (31) | 7 (35) | 0.50 |
| Sufentanil (μg) | 103 [90–118] | 108 [94–128] | 0.26 |
| Duration anesthesia (h) | 10 [9–11] | 9 [9–10] | 0.48 |
| Time to extubation (h) | 5 [4–6] | 5 [4–6] | 0.90 |
Date are presented as median [IQR] or n (%)
AVR aortic valve replacement, MVR mitral valve replacement, CABG coronary artery bypass graft surgery, Euroscore 2 European System for Cardiac Operative Risk Evaluation: risk model which allows the calculation of the risk of death after a heart operation